CXCL8/IL-8 Rekombinanter Antikörper

CXCL8/IL-8 Rekombinant Antikörper für FC (Intra)

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

FC (Intra)

Konjugation

Unkonjugiert

CloneNo.

240889B2

Kat-Nr. : 98137-1-RR

Synonyme

CXCL8, IL8, IL-8, C-X-C motif chemokine 8, C-X-C motif



Geprüfte Anwendungen

Erfolgreiche Detektion in FC (Intra)IFN gamma, LPS and Brefeldin A treated human PBMCs

Empfohlene Verdünnung

AnwendungVerdünnung
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Produktinformation

98137-1-RR bindet in FC (Intra) CXCL8/IL-8 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Rekombinantes Protein
Vollständiger Name interleukin 8
Berechnetes Molekulargewicht 99 aa, 11 kDa
GenBank-ZugangsnummerBC013615
Gene symbol IL-8
Gene ID (NCBI) 3576
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS with 0.09% sodium azide
LagerungsbedingungenStore at 2 - 8°C. Stable for one year after shipment.

Hintergrundinformationen

Interleukin 8 (IL-8), also known as CXCL8, is a CXC chemokine family member. This chemokine is secreted by a variety of cell types including monocyte/macrophages, T cells, neutrophils, fibroblasts, endothelial cells, and various tumor cell lines in response to inflammatory stimuli. IL-8 has two primary functions. It induces chemotaxis in target cells, primarily neutrophils but also other granulocytes, causing them to migrate toward the site of infection. IL-8 also induces phagocytosis once they have arrived. This gene is believed to play a role in the pathogenesis of bronchiolitis, a common respiratory tract disease caused by viral infection. IL-8 is also known to be a potent promoter of angiogenesis. IL-8 has been associated with tumor angiogenesis, metastasis, and poor prognosis in breast cancer. IL-8 may present a novel therapeutic target for estrogen driven breast carcinogenesis and tumor progression.

Protokolle

PRODUKTSPEZIFISCHE PROTOKOLLE
FC protocol for CXCL8/IL-8 antibody 98137-1-RRDownload protocol
STANDARD-PROTOKOLLE
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen